Skip to content

    Recently Viewed


      Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference

      Share Article
      share to

      NEW BRUNSWICK, N.J., Oct. 25, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 26th Annual Credit Suisse Health Care Conference on Wednesday, Nov. 8, at The Phoenician in Scottsdale, AZ. Vanessa Broadhurst, President, Cardiovascular & Metabolism, Janssen Pharmaceuticals and Scott White, President, Immunology, Janssen Pharmaceuticals will represent the Company in a session scheduled at 9:50 a.m. (Mountain Standard Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at

      A webcast and podcast replay will be available approximately two hours after the live webcast.

       (PRNewsfoto/Johnson & Johnson)

      SOURCE Johnson & Johnson

      Press Contacts: Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M); Investor Contacts: Joseph Wolk, (732) 524-1142; Lesley Fishman, (732) 524-3922

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.